Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Ionis Pharmaceuticals, Inc.”

202 pharma patents match "Ionis Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 202
Index total 30,257
Page 5 / 9

Quick answer

This filtered view shows 202 pharmaceutical patents matching "Ionis Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

202 results for “Ionis Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 10837016

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  2. US 10822369

    Compounds and methods for the modulation of proteins

    Ionis Pharmaceuticals, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  3. US 10815480

    Modulation of alpha synuclein expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  4. US 10815483

    Compositions for modulating C9ORF72 expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  5. US 10793855

    Compositions for modulating expression of C9ORF72 antisense transcript

    Ionis Pharmaceuticals, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  6. US 10793862

    Compositions and methods for modulating growth hormone receptor expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  7. US 10772906

    Modulation of Factor 11 expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  8. US 10774333

    Modulators of PNPLA3 expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted
  9. US 10751419

    Method for synthesis of reactive conjugate clusters

    Ionis Pharmaceuticals, Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  10. US 10683499

    Compositions and methods for modulating TTR expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted
  11. US 10655129

    Compositions and their uses directed to huntingtin

    Ionis Pharmaceuticals, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  12. US 10619157

    Cancer treatment

    Ionis Pharmaceuticals, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  13. US 10619158

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted
  14. US 10577604

    Methods for monitoring C9ORF72 expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  15. US 10577607

    Modulation of DYRK1B expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  16. US 10570169

    Conjugated antisense compounds and their use

    Ionis Pharmaceuticals, Inc. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  17. US 10557137

    Modulating apolipoprotein (a) expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  18. US 10538763

    Compounds and methods for modulation of DUX4

    Ionis Pharmaceuticals, Inc. · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted
  19. US 10533175

    Compositions and methods for modulating Ataxin 3 expression

    Ionis Pharmaceuticals, Inc. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted
  20. US 10526604

    Modulation of nuclear-retained RNA

    Ionis Pharmaceuticals, Inc. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted
  21. US 10517953

    Modulators of PCSK9 expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted
  22. US 10517889

    Modulators of SMAD7 expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted
  23. US 10493092

    Antisense compounds

    Ionis Pharmaceuticals, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted
  24. US 10479993

    Modulation of signal transducer and activator of transcription 3 (STAT3) expression

    Ionis Pharmaceuticals, Inc. · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted